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Abstract  Epistaxis  is  deﬁned  as  ﬂow  of  blood  from  the  nasal  fossae  and  is  a  common  and
benign disorder  in  the  great  majority  of  cases  which  does  not  require  medical  care.  It  may
however  become  a  genuine  medical  or  surgical  emergency  because  of  the  amount,  repeated
episodes  or  patient’s  medical  vulnerability  (such  as  coronary  artery  disease  patients).  Epistaxis
may be  either  primary  or  a  symptom  of  an  underlying  disease.  Four  levels  of  problems  need  to  be
answered faced  with  epistaxis:  recognizing  it,  and  in  particular  not  missing  ‘‘epistaxis’’  due  to
swallowed blood  or  venous  hemorrhage,  which  falls  outside  of  the  scope  of  interventional  radi-
ology; establishing  the  amount  and  its  repercussions,  particularly  as  a  decompensating  factor
in another  disease;  investigating  its  cause  and  in  particular  never  missing  a  tumor  (male  adoles-
cents); obtaining  hemostasis.  Epistaxis  varies  not  only  in  type  and  cause  but  must  be  considered
in its  clinical  context.  Arterial  embolization  is  a  treatment  of  choice  for  severe  refractory  epis-
taxis and  some  hemorrhages.  When  carried  out  by  trained  operators,  it  is  an  effective  method
with few  risks  of  complications  and  is  increasingly  being  used  in  reference  centers  (Brinjikji
et al.).  It  remains,  however,  a  method  which  is  less  widely  used  than  surgery,  particularly  in  the
United States  where  in  a  series  of  69,410  patients  treated  over  the  last  10  years  for  refractory
epistaxis, 92.6%  underwent  surgical  ligation,  6.4%  embolization  and  1%  combined  treatments
(Brinjikji et  al.).  Epistaxis  is  occasionally  catastrophic  and  requires  extremely  urgent  manage-
ment. In  each  case,  close  collaboration  with  the  surgeon,  the  presence  of  an  intensive  care
anesthetist  and  at  least  sedation  are  all  factors  which  improve  management  and  therefore
the results  of  embolization.  All  patients  and/or  their  friends/close  family  should  have  given
‘‘reliable, clear  and  appropriate’’  information.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
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blood  supply  (Fig.  3)  and  this  is  therefore  the  artery  most
F58  
eneral points
pistaxis  has  a  prevalence  of  approximately  60%  in  the  adult
opulation  and  is  the  commonest  acute  disorder  seen  in
ar-nose  and  throat  clinical  practice.  The  natural  history  of
pistaxis  is  that  it  recovers  untreated  in  the  great  majority
f  cases.  According  to  Small  et  al.  [1],  only  6%  of  cases  of
pistaxis  require  medical  treatment  although  some  may  be
atal  without  treatment.
The  causes  can  be  divided  into  two  subgroups:  an  idio-
athic  (or  essential)  group  and  a  ‘‘symptomatic’’  group
n  which  the  epistaxis  is  the  symptom  of  an  underlying
isease.
More  than  70%  of  cases  are  ‘‘idiopathic’’  or  ‘‘essential’’
2].  The  majority  of  cases  of  essential  epistaxis  are
elated  to  risk  factors  [3],  which  are  hypertension,
ypercholesterolemia,  smoking,  the  NSAID  (mostly  aspirin)
nd  coagulation  disorders.  The  organic  causes  of  symp-
omatic  epistaxis  (Fig.  1)  are  trauma,  surgery  partic-
larly  trans-sphenoidal  [4],  ENT  tumors,  malformations
uch  as  hereditary  hemorrhagic  telangiectasiae  (Rendu-
sler  disease)  [5]  or  occasionally  carotid-cavernous  sinus
stulae  [6].
Regardless  of  the  cause,  epistaxis  can  be  serious  and
ife  threatening.  When  it  is  ﬁrst  seen,  it  is  important
o  assess  the  amount  and  repetition  of  blood  losses
nd  carry  out  a  general  laboratory  assessment  (coagu-
ation,  complete  blood  count  and  grouping).  In  severe
o
u
igure 1. Causes of refractory epistaxis by incidence, from ChristenseA.  Reyre  et  al.
pistaxis,  patients  should  be  managed  in  a  specialist  ENT
nit.
ractical radiological anatomy
 full  knowledge  of  the  branches  of  the  external  carotid
rtery  is  an  essential.  These  should  be  identiﬁed  by  con-
entional  angiography  after  selective  catheterization  of  the
xternal  carotid  artery  (Figs.  2—10).
ormal radiological anatomy
he  sphenopalatine  artery  is  the  artery  usually  responsi-
le  for  refractory  epistaxis.  This  can  be  occluded  surgically
hrough  an  endonasal  approach  or  it  can  be  embolized.  Pos-
ible  hazardous  anastomoses  with  branches  of  the  external
arotid  artery  can  result  in  visual  or  central  deﬁcits  per-  or
ost-embolization.
The  vascular  blush  is  an  anastomotic  plexus  made  up  of
rterial  branches  (second  order)  from  the  external  carotid
rtery,  described  by  Kiesselbach.  This  is  located  in  the
ntero-inferior  part  of  the  nasal  septum  and  is  the  site  of
ver  90%  of  epistaxis.  The  sphenopalatine  artery  is  its  mainften  involved  in  idiopathic  epistaxis.
Other  branches  of  the  maxillary  artery  should  also  be
nderstood.
n et al. in 2005 [10].
Epistaxis:  The  role  of  arterial  embolization  759
Figure 2. Dividing branches of the external carotid artery after selective catheterization. Selective arteriography of the external carotid
artery (a), and ﬂat panel CT angiography (b). 1: lingual artery; 2: facial artery; 3: occipital artery; 4: superﬁcial temporal artery; 5: internal
maxillary artery; 6: ascending pharyngeal artery.
Figure 3. Sphenopalatine artery. Selective arteriography of the external carotid artery (a) and ﬂat plane CT (FPCT) 3D oblique coronal
(b) and axial (c) reconstructions. The sphenopalatine artery (a: white arrows) is a branch of the maxillary artery. It passes through the
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•sphenopalatine foramen (b, c: white arrows) before entering the n
and posterior septal branches (b: arrowheads).
Anastomoses between internal and external
carotid artery territories
A  variable  number  of  anastomoses  exist  between  branches  of
the  internal  and  external  carotid  arteries  (aIC-aEC)  carrying
a  risk  of  neurological  accidents  with  off-target  emboliza-
tion.  These  ‘‘hazardous’’  anastomoses  should  always  be
looked  for  (Fig.  11).  Only  the  ethmoidal  arteries  routinely
contribute  to  the  vascular  supply  of  the  nasal  fossae.  The
anterior  and  posterior  ethmoidal  arteries  arise  from  the  oph-
thalmic  artery  (which  itself  is  the  ﬁrst  collateral  branch  of
the  internal  carotid  artery)  and  supply  the  upper  part  of  the
superior  nasal  concha  and  the  most  superior  part  of  the  nasal
fossae.cavity, where it divides into lateral posterior, posterior turbinate
he place of diagnostic imaging
 routine  supra-aortic  vessel  CT  angiogram  (SAOV)  is  recom-
ended  before  any  treatment  procedure.  If  the  epistaxis  is
eemed  to  be  severe,  treatment  should  be  given  without
elay.
This  must  include  an  image  in  the  arterial  phase  and  an
mage  in  the  tissue  phase.  These  have  two  uses:
etiologic:  they  can  be  used  to  investigate  for  an  under-
lying  disease  as  the  cause  of  the  epistaxis  (symptomatic
epistaxis):
◦ tumor:  investigation  for  a  mass  in  the  nasal  fossae  or
cavum  or  vascular  lesions  (wall  irregularities,  pseudoa-
neurysm),
760  A.  Reyre  et  al.
Figure 4. Middle meningeal artery. Selective arteriography of the external carotid artery (a) and ﬂat panel CT (FPCT) 3D oblique coronal
(b) and axial (c) reconstructions. The middle meningeal artery (a, b: white arrow) is generally the second superior branch of the maxillary
artery after the superﬁcial temporal artery (a, b: arrowhead). After its origin, it travels vertically in the infratemporal fossa entering
the cranium (c: arrows) through the spinous foramen and supplies the dura mater. It is not responsible for epistaxis and does not require
embolization in this situation. Its anatomical position generally allows it to be preserved.
Figure 5. Infra-orbital artery. Selective arteriography of the external carotid (a) and ﬂat panel 3D (FPCT) oblique coronal (b) and axial
(c) reconstruction. The infra-orbital artery arises from the distal portion of the internal maxillary artery and enters the infra-orbital canal
where it travels jointly with the infra-orbital nerve (a branch of V2). Before emerging through the infra-orbital foramen, it divides into
an orbital branch supplying the inferior rectus muscle and the lachrymal sac and an anterior branch supplying the superior dental tissues
and maxillary sinus mucosa. Some of its branches may anastomose superiorly with the facial artery (through the angular artery) or the
ophthalmic artery (through dorsal nasal branches of the ophthalmic artery). It is not therefore directly responsible for posterior epistaxis
but because of its anatomical site, it is rarely preserved.
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Figure 6. Descending palatine artery. Selective arteriography of the external carotid (a) and ﬂat plane 3D (FPCT) oblique coronal (b)
and axial (c) reconstruction. Descending palatine artery arises from the distal portion of the internal maxillary artery (a: arrow), crosses
the maxillary nerve (V2) next to the pterygopalatine ganglion in the pterygopalatine groove (b: arrowhead) and gives rise to a descending
vertical portion (b: arrow) in the greater palatine nerve canal (c: arrow) where it travels together with the nerve carrying the same name.
It supplies the propharyngeal mucosa in the soft palate and upper gums. It is therefore not directly responsible for posterior epistaxis but
because of its anatomical site, it is rarely preserved.
Figure 7. Inferior alveolar artery. Selective arteriography of the external carotid (a) and ﬂat panel 3D (FPCT) oblique coronal (b) and
axial (c) reconstruction. The inferior alveolar artery arises from the initial portion of the internal maxillary artery (a: arrowhead) on its
inferior surface. It then runs downwards and anteriorly to join the inferior alveolar canal which it enters at the Spix spine (b, c: arrow). It
runs together with the inferior alveolar nerve to the mental foramen where it gives rise to a median incisor branch, a mental branch which
anastomoses with branches of the facial artery and a branch supplying the mylohyoid muscle. It is not responsible for epistaxis and does
not require embolization in this situation. Because of its anatomical site, it can usually be preserved.
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Figure 8. Ascending pharyngeal artery. Selective arteriography of the external carotid (a) and ﬂat panel 3D (FPCT) oblique coronal (b) and
axial MIP (c) reconstruction. The ascending pharyngeal artery arises from the initial portion of the external carotid artery immediately above
the bifurcation of the common carotid artery (a: arrow). It is the smallest branch of the external carotid artery and runs in an ascending
vertical plane in the carotid space. It separates into three vessels. The ﬁrst is an anterior palatine vessel. The second is an anterior pharyngeal
vessel which contributes to the supply to the nasopharyngeal mucosal space and pharyngeal muscles (pharyngeal constrictors and styloid
septum muscles: b, c: arrow). Finally, the ascending pharyngeal artery gives rise to a posterior neuromeningeal vessel (a: arrowhead), which
enters the base of the cranium at the hypoglossal jugular foramen and which contributes to supplying the mixed nerves (vasa nervorum)
(IX, X, XI) and the hypoglossal nerve (XII). The neuromeningeal trunk (posterior) of the ascending pharyngeal artery is not therefore directly
responsible for posterior epistaxis and because of its anatomical site, it can usually be preserved. Embolization of this vessel carries risks
of neuronal damage.
Figure 9. Ascending palatine artery. Selective arteriography of the external carotid (a) and ﬂat panel 3D (FPCT) sagittal MIP (b) and axial
MIP (c) reconstruction. The ascending palatine artery (a: arrows) varies in origin and usually arises from the initial portion of the external
carotid artery (b: arrow) close to the facial artery [23] (b: arrowhead). Amongst other things, it supplies the palatine tonsils, the roof of the
palate and the Eustachian tube (c: arrows). Because of its many anastomoses, it may make a minor contribution to the posterior vascular
supply of the ﬂoor of the nasal fossae. It is believed to be difﬁcult to catheterize and embolization of this vessel is therefore only rarely an
angiographic target to treat refractory epistaxis.
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Figure 10. Facial artery. Hyperselective arteriography of the facial artery (a) and selective arteriography of the external carotid artery
in coronal MIP (b) and axial MIP (c) 3D ﬂat plane capture CT plan (FPCT) reconstructions. A branch of the external carotid artery, the facial
artery, supplies the superﬁcial planes of the face. Through its terminal branches, it supplies the anterior nasal region through the superior
labial artery (a: arrow) which gives rise to the infraseptal artery at the internal canthus (b: grey arrow) where it is not unusual for it to have
lized
ips as
on of
•anastomoses with the ophthalmic artery system. It is usually embo
hazardous anastomoses and possible unsightly discoloration of the l
as a result of persistent epistaxis immediately following embolizati
◦ vascular  malformation:  investigation  for  arteriovenous
shunts,◦ rendu-Osler  disease:  investigation  for  telangiectasiae,
◦ post-traumatic  or  postoperative:  investigation  for  an
active  leak,  pseudoaneurysms  or  wall  irregularities;
Figure 11. Example of aIC-aEC anastomoses in a 62-year-old female pa
the external carotid artery (a) shows the presence of ‘‘blushes’’ in the 
with the internal carotid system. Note the absence of opaciﬁcation of 
embolization. Selective angiography of the internal carotid artery (b) and
shows a large anastomotic network between the internal and external c
nasal fossae and nasopharynx. The ethmoidal (b: arrows) arteries are op
(a: foramen lacerum artery, foramen rotundum artery and pterygoid fora
b: arrowheads) are both opaciﬁed by the two arterial systems showing a
difﬁcult. Note the aneurysms at the ending of the carotid artery (c: arro second line and embolization should take account of potentially
 a result of colored microbeads Embolization is usually carried out
 the sphenopalatine arteries.
preoperative:
◦ with  a  view  to  endovascular  treatment:  anatomy  of  theSAOV,  atheroma  (risk  of  CVA),
◦ with  a  view  to  surgery:  identiﬁcation  of  the  sphenopala-
tine  foramen  and  ethmoidal  arteries.
tient suffering from Rendu Osler disease. Selective angiography of
nasal fossa mucosa (a: arrow) without any anastomosis being seen
the internal maxillary artery because of prior proximal microcoil
 3D ﬂat panel image (c: ﬂat panel CT) in sagittal MIP reconstruction
arotid artery systems contributing posterior vascularization to the
aciﬁed together with multiple arteries at the base of the cranium
men artery; c: arrows). Branches of the sphenopalatine artery (a,
IC-aEC anastomoses and making possible embolization particularly
wheads).
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its  emergence  (sphenopalatine  foramen)  into  the  posterior
part  of  the  nasal  fossa  and  is  effective  in  75%  to  85%  of  cases
(or  even  more  in  very  experienced  hands).  Its  limitations  are64  
CT  angiography  is  usually  normal  in  essential  epistaxis.
ssessment of severity
efore  any  treatment  is  given,  it  is  essential  to  deﬁne
hether  the  epistaxis  is  mild  or  severe.  Diagrammatically,
wo  clinical  pictures  can  be  distinguished.
ild epistaxis
lood  ﬂow  is  not  particularly  heavy  and  comes  in  drops  from
he  nostril.  It  almost  always  begins  unilaterally.  ORL  exam-
nation  is  straightforward  after  the  patent  has  wiped  their
ose  and  anterior  rhinoscopy  shows  the  site  of  the  bleeding,
hich  is  generally  anterior  in  Kiesselbach’s  plexus.  This  has
o  consequences  on  the  patient’s  general  condition.
evere epistaxis
he  severity  of  epistaxis  depends  on  different  factors,  which
hould  be  assessed  immediately:
the  presence  of  hemorrhagic  shock;
a  fall  in  hemoglobin:  epistaxis  is  deemed  to  be  severe  if
the  blood  hemoglobin  is  under  8  g;
the  amount:  this  is  not  so  much  assessed  by  whether  the
epistaxis  is  bilateral  or  anteroposterior  but  using  objec-
tive  concepts  such  as  heart  rate  (pulse),  blood  pressure,
sweating  and  pallor.  Volume  is  always  difﬁcult  to  esti-
mate  and  is  often  over-estimated  by  the  patient  or  the
patient’s  friends/family,  but  can  be  underestimated  if  it
is  swallowed;
the  duration  or  repetition  of  epistaxis  should  be  con-
ﬁrmed;
association  with  a  disease  liable  to  decompensate  because
of  blood  loss  such  as  coronary  artery  disease  or  carotid
artery  stenosis;
the  presence  of  coagulation  abnormalities  (such  as  anti-
coagulation  therapy)  occasionally  makes  control  of  the
bleeding  more  difﬁcult.
The  nasal  cavities  are  occasionally  difﬁcult  to  examine
ecause  of  the  amount  of  the  bleed  which  is  often  bilateral
nd  anteroposterior.
reatment of essential epistaxis
his  depends  on  how  benign  or  severe  the  epistaxis  is.
If  the  epistaxis  is  symptomatic,  treatment  is  that  of  the
nderlying  cause,  which  will  be  discussed  in  the  next  sec-
ion.
f the epistaxis is benign
he  treatments  follow  a  ‘‘crescendo’’  sequence,  increasing
n  step  in  the  following  order:Local  treatment:  ‘‘minor  measures’’:
manual  bidigital  compression  for  very  anterior  bleeding;
anterior  meshing  by  applying  hemostatic  meshes
(Merocel®);
F
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endoscopic  electrocoagulation  with  bipolar  diathermy
forceps  under  local  anesthesia  if  an  anterior  lesion  is  vis-
ible;
if  this  fails:
◦ anteroposterior  tamponade:  this  is  usually  a  treatment
for  posterior  rather  than  anterior  epistaxis.  In  the  latter
situation,  anterior  and  posterior  tamponade  should  be
applied  using  a  dual  balloon  tube  (Fig.  12);
if  this  fails:
◦ here  again,  posterior  epistaxis  is  usually  the  cause,
◦ anteroposterior  tamponade  may  be  ineffective  in  a
number  of  cases  (25  to  52%  depending  on  the  series),
this  is  deﬁned  as  failure  of  two  posterior  tamponades
over  48  h,
◦ in this  situation,  the  epistaxis  is  said  to  be  refractory
and  is  deemed  to  be  severe.  This  therefore  requires
surgery  or  endovascular  treatment.
f the epistaxis is deemed to be severe from
he outset (or refractory)
n  practice,  severe  epistaxis  should  be  treated  initially  by
nteroposterior  tamponade.
If  it  is  life  threatening  (hemorrhagic  shock,  fall  in
emoglobin  to  under  8  g),  if  bleeding  persists  (refractory
pistaxis)  or  on  a background  of  a  very  serious  underlying
ause,  it  should  be  treated  surgically  (electrocoagulation
f  the  sphenopalatine  artery)  or  through  an  endovascular
adiological  approach  (arterial  embolization).
If  anterior  tamponade  fails,  the  dual  balloon  tube  is
ntroduced  as  far  as  the  rhinopharynx  (Fig.  12).  The  poste-
ior  balloon  (arrow)  is  inﬂated  moderately  and  blocked  in  the
hoana.  The  anterior  balloon  (arrowhead)  is  then  inﬂated  in
he  vestibule  of  the  nostril  to  isolate  the  whole  nasal  fossa.
he  balloons  should  be  ﬁlled  with  water  and  deﬂated  every
 hours  to  avoid  mucosal  necrosis.
urgery
urgery  can  be  useful  for  uncontrolled  bleeding.  Different
ypes  of  surgery  are  possible:  endonasal  electrocoagulation
f  the  sphenopalatine  artery  (Fig.  13)  involves  using  bipolar
iathermy  forceps  to  coagulate  the  sphenopalatine  artery  atigure 12. Dual balloon catheter for anterior and posterior tam-
onade.
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Figure 13. Endonasal electrocoagulation (endoscopic) of the F
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asphenopalatine artery for refractory epistaxis: the sphenopalatine
artery is coagulated by bipolar diathermy forceps (arrow).
mucosal  damage  making  it  difﬁcult  to  view  the  artery  and
heavy  bleeding  due  to  blood  coagulopathies.
The  ethmoidal  arteries  are  usually  ligated  if  emboliza-
tion  fails  if  post-embolization  views  show  revascularization
of  the  nasal  fossa  by  the  anterior  or  posterior  ethmoidal
artery.
Ligation  of  the  anterior  ethmoidal  artery  is  usually  per-
formed  by  a  surgical  approach  through  the  surgical  approach
internal  canthus  rather  than  endonasally.  The  posterior  eth-
moidal  artery  is  ligated  in  recurrence  of  bleeding  despite
ligating  the  anterior  ethmoidal  artery.
Ligation  of  the  external  carotid  artery  through  cervi-
cotomy  is  a  technique  which  has  now  been  abandoned
except  in  very  rare  cases  as  it  obstructs  access  to  future
embolization.  Ligating  the  internal  maxillary  artery  through
a  vestibular  approach  is  a  demanding  technique  which  is
poorly  suited  to  emergency  use  and  is  rarely  carried  out.
Endovascular treatment
Anterior  essential  epistaxes  are  not  treated  by  embolization
unless  symptomatic  treatment  and/or  surgery  have  failed.
Posterior  epistaxis  is  a  good  indication  for  embolization  [8]
(Fig.  14)  if  the  epistaxis  is  severe  from  the  outset  (hemor-
rhagic  shock  or  large  fall  in  hemoglobin  with  a  hemoglobin
of  under  8  g)  or  if  two  posterior  tamponades  have  failed  over
more  than  48  hours  (refractory  epistaxis).
Embolization  technique:
• femoral  approach  with  a  valve  introducer  (6F  if  possible);
• selective  catheterization  of  the  common  internal  and
external  carotid  artery  (if  possible  using  a  guide  catheter)
ipsilateral  to  the  bleeding  (and  possibly  contralateral  if
the  bleeding  side  is  not  identiﬁed  on  ENT  examination);
• microcatheterization  (0.021  inch)  of  the  arteries  to  be
embolized.  Flexible  ‘‘navigating’’  microcatheters  should
be  used  in  preference  to  avoid  arterial  spasm.The  arterial  architecture  and  bleeding  areas  should  be
identiﬁed  on  anteroposterior  and  lateral  views.  Anasto-
moses  with  the  cerebral  or  ophthalmic  arterial  territories
must  be  identiﬁed,  together  with  those  between  the
a
e
aigure 14. Topography of the arteries usually embolized for
efractory epistaxis, from Christensen et al. [10].
phenopalatine  and  anterior  ethmoidal  arteries  via  the
urbinate  and  infra-orbital  arteries.  Catheterization  of
rteries  to  the  neck  (subclavian  artery  and  its  branches)
s  generally  not  required  in  idiopathic  epistaxis  although
s  essential  in  other  cases  of  ENT  hemorrhage,  particularly
ostoperatively  in  patients  who  have  undergone  laryngec-
omy  and  are  bleeding  from  their  tracheostomy  cannula.
Hemorrhage  from  the  anterior  ethmoidal  artery  requires
urgical  treatment  and  is  not  treated  endovascularly
ecause  of  the  dangers  associated  with  microcatheterizing
he  ophthalmic  artery.
Embolization  of  the  ipsilateral  sphenopalatine  artery  is
ufﬁcient  in  most  cases  and  may  be  combined  with  emboliza-
ion  of  the  ipsilateral  facial  artery  (Fig.  15),  which  is  very
ften  anastomosed  with  the  sphenopalatine  artery  through
he  infra-orbital  artery  (which  signiﬁcantly  reduces  the
ecurrence  of  hemorrhage)  (Fig.  5).  In  bilateral  epistaxis,
oth  sphenopalatine  and  facial  arteries  may  be  embolized.
In  some  cases,  other  branches  of  the  external  carotid
rtery  may  restore  ﬂow  to  the  ending  of  the  sphenopalatine
rtery  and  the  internal  maxillary  artery  through  counter-
urrent  anastomoses.  These  only  occasionally  develop  after
cclusion  of  the  main  trunk  and  can  then  be  catheterized
nd  occluded.
cclusion  materials
he  choice  of  occlusion  material  depends  mostly  on  the
ause  of  the  epistaxis.  Microparticles  are  preferable  in  most
ases  of  essential  epistaxis  when  non-resorbable  micro-
articles  with  a diameter  of  over  500  microns  in  size  are
xtremely  effective.  These  should  however  be  avoided  if
nastomoses  are  present  between  the  sphenopalatine  ter-
itory  and  the  territory  of  the  anterior  ethmoidal  artery,
articularly  if  these  two  territories  are  contributing  to  the
pistaxis.  In  order  to  be  used,  they  require  free-ﬂow  injec-
ion  and  radioscopy  monitoring  to  avoid  any  risk  of  reﬂux
nd  to  identify  anastomoses  which  are  unmasked  second-
rily.  These  microparticles  can  cause  complications  during
mbolization  of  the  facial  artery  (skin  necrosis  and  pain).
Insertion  of  microcoils  may  be  a good  alternative:  these
re  either  ‘‘ﬂushable’’  or  controlled  release.  They  should
766  A.  Reyre  et  al.
Figure 15. Embolization of essential refractory epistaxis. Eighty-two-year-old female patient with left refractory essential epistaxis
despite correct medical treatment. Left common carotid arteriography (a) shows vascularization of the posterior nasal fossa mostly through
branches of the internal maxillary artery but also from branches of the ophthalmic artery (a: ethmoidal) and to a lesser extent by branches
of the facial artery. Hyperselective arteriography of the internal maxillary artery (b) shows modal anatomy and no anastomoses seen
in the internal carotid artery territory, particularly the ophthalmic region. A repeat view after ipsilateral embolization of the internal
maxillary artery with 700 m microparticles (Embozen® Microspheres, CeloNova Biosciences Inc, San Antonio, Tx, USA) shows complete
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revascularization of the nasal fossa as a result of obstruction of the
he surgical team conﬁrmed the immediate success of the procedu
e  positioned  distally  in  contact  with  the  hemorrhagic  area.
hey  have  the  disadvantage  of  permanently  obstructing  the
rtery  and  occluding  one  of  the  targets  for  possible  re-
mbolization  in  the  event  of  a  recurrence.
Cyanoacrylate  glues  (Glubran  2® or  Histoacryl®)  are  dif-
cult  to  use  and  require  operators  trained  in  their  use
7].  They  are  immediately  effective  but  are  reserved  for
ife-threatening  cases.  Embolization  with  Onyx® is  more
traightforward  and  carries  less  risk  of  off-target  emboliza-
ion  than  the  cyanoacrylates.  This  requires  good  knowledge
f  the  toxicity  and  delivery  of  the  substance  [8]. When  it
s  used  in  branches  of  the  internal  maxillary  artery,  the
imethylsulfoxide  contained  in  Onyx® can  cause  profound
radycardia  due  to  a  trigemino-cardiac  reﬂex  [9].
esults:  success,  recurrence  and  complications
he  technical  success  rate  of  embolization  is  high,  in  the
egion  of  80  to  88%  [10].  Complications  may  occur  in  8%—13%
f  cases  [10—12].  The  most  recent  studies  show  better
esults  probably  due  to  advances  in  techniques,  operators,
he  materials  available  to  them  and  embolization  agents
microcoils,  microparticles,  etc.).
There  is  a  wide  range  of  potential  complications  after
ndovascular  treatment  of  epistaxis.  In  addition  to  recur-
ence  of  hemorrhage,  the  literature  reports  cases  of  facial
euralgia,  septal  perforation,  sinusitis,  and  otitis  media.
ystemic  complications  may  also  occur,  including  inhalation
ypoxia,  hypovolemia,  angina  and/or  myocardial  infarction.
he  meta-analysis  reported  by  Cullen  on  539  patients  not
nly  identiﬁed  the  different  complications  of  endovascu-
ar  treatment  but  compared  their  incidence  with  those  of
urgery  [13].
a
c
t
sillary artery (black arrowheads). A per-procedure clinical check by
The  most  severe  complications  of  arterial  embolization
re  cerebrovascular  accident  and  obstruction  of  the  central
rtery  of  the  retina.  Depending  on  the  series,  these  occur  in
etween  0  and  2%  of  cases  [14]. In  Brinjikji’s  retrospective
nalysis  [15]  on  a  population  of  64,289  patients  treated  in
he  United  States  between  2003  and  2010,  the  CVA  rate  was
ound  to  be  signiﬁcantly  higher  after  embolization  (0.9%)
han  after  surgery  (0.1%)  (Fig.  16).
These  results  raise  questions.  It  is  likely  that  the  increas-
ng  use  of  minimally  invasive  endoscopic  techniques  to  ligate
he  sphenopalatine  artery  is  improving  patient  management
nd  secondly,  the  experience  of  interventional  radiologists,
he  state  of  the  patient’s  arterial  system  and  embolization
gents  are  all  factors  which  inﬂuence  development  of  CVA.
nly  a few  authors  have  produced  a critical  analysis  of  the
mbolization  materials  and  agents  used  in  this  situation.
outine  use  of  microcatheterization  is  contributing  towards
 reduction  in  the  incidence  of  CVA  [3].
In  terms  of  procedure  costs,  data  from  the  studies  are
ontroversial  probably  because  of  the  differences  in  price  of
he  various  embolization  agents  which  can  be  used  and  dif-
erences  in  cost  of  the  radiology  and  surgical  environments.
mbolization  appears  to  be  more  expensive  in  surgery  [16],
lthough  this  excess  cost  is  usually  compensated  by  shorter
ospitalization  stays  for  embolization  [17].
Early  rebleeding  after  embolization  is  usually  treated  by
urther  embolization  unless  blood  ﬂow  has  obviously  been
estored  through  the  ethmoidal  arteries.  Collateral  vessels
re  examined  angiographically  (the  anterior  ethmoidal  and
ontralateral  external  carotid  arteries).  Occlusion  of  the
wo  facial  arteries  and  two  sphenopalatine  arteries  is  a  pos-
ible  option.
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artery  can  lead  to  paralysis  of  mixed  nerves  and  shouldFigure 16. Comparative morbidity and mortality (surgery compar
CVA  due  to  off-target  embolization  is  managed  conven-
tionally.
Post-embolization  neuropathy  is  treated  with  corticoste-
roids.
Secondary epistaxis
Embolization of branches of  the external
carotid artery in ENT oncology
Epistaxis  generally  involves  neoplastic  sites  in  the  nasopha-
rynx  (Fig.  17).  The  incidence  of  this  complication  is  low  in
cervicofacial  surgery  (4.3%)  [17]  although  external  radio-
therapy  increases  the  risk  by  a  factor  of  7.6  [18,19].
The  bleeding  may  arise  from  the  tumor  by  erosion  of
vascular  structures  which  are  invaded,  particularly  in  pro-
gressive  disease  [22],  but  may  occur  as  a  result  of  tumor
necrosis  in  patients  who  have  responded  very  well  to
treatment.  The  hemorrhage  may  occur  on  a  background
of  complete  remission  as  a  result  of  irradiation-induced
damage,  in  which  case  it  is  promoted  by  a  local  inﬂam-
matory  factor  (osteoradionecrosis,  tracheostomy  cannula,
orostome).  Occasionally,  hemorrhage  in  the  postoperative
period  may  be  due  to  loosening  of  a  vascular  structure
(reconstruction  ﬂap).  Endovascular  (hemostatic)  treatment
is  an  option  with  a  recognized  indication  [18]. The  gen-
eral  principles  of  embolizing  branches  of  the  external
carotid  artery  are  the  same  as  for  essential  epistaxis
(Appendix).Rendu-Osler disease
Rendu-Osler  disease  or  hereditary  hemorrhagic  telangiec-
tasiae  is  an  autosomal  dominant  transmitted  angiomatosis
b
g
t
d embolization), from Brinjikji et al. in 2013 [15].
elonging  to  the  phacomatoses  group.  It  is  managed  in  a
ultidisciplinary  setting  in  a  local  or  regional  center.
Epistaxis  is  the  most  common  clinical  feature  and  recurs
requently.
ENT  embolization  is  only  considered  in  patients  with
requent  episodes  of  bleeding  who  cannot  live  a  sat-
sfactory  everyday  life.  Embolization  is  performed  by
icroparticles  (between  500  and  700  m  in  size)  (Fig.  18)
s  distally  as  possible,  preserving  the  arterial  pedicles
ascularizing  the  nasal  fossae  to  allow  repeated  emboliza-
ions.  Microcoils  are  therefore  not  recommended  or  even
ontra-indicated  in  order  to  avoid  occluding  the  approach
oute.
mbolization of benign tumors
ost  cases  involve  preoperative  embolization  and  the
umors  involved  are  mostly  nasopharyngeal  (angio-)ﬁbromas
Figs.  19—21)  and  occasionally  paragangliomas  which  may
e  embolized  preoperatively  to  reduce  the  risk  of  surgical
leeding  [20,21].
Angioﬁbromas  occasionally  have  a  signiﬁcant  vascular
omponent  from  the  internal  carotid  artery.  Embolization  of
he  internal  carotid  artery  territory  carries  neurological  risks
nd  should  be  reserved  for  extremely  specialized  centers.
Embolization  of  the  sphenopalatine  artery  is  generally
nsufﬁcient  and  devascularization  requires  the  facial  artery
nd  ascending  pharyngeal  artery  to  be  embolized,  occasion-
lly  bilaterally.  Embolization  of  the  ascending  pharyngeale  carried  out  with  caution  with  preoperative  preference
iven  to  microcoils.  Anastomoses  may  exist  with  the  ver-
ebrobasilar  territory  which  should  be  looked  for  carefully
uring  diagnostic  arteriography.
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Figure 17. Epistaxis from a round, median nasopharyngeal tissue lesion vascularized on CT (a: arrowheads) seen as an isointense appear-
ance on T2-weighted imaging (b: arrowheads), with reduced diffusion (ADC = 0.5 × 10−3 mm2/sec, c: arrowheads) and vivid enhancement
after IV of gadolinium chelate on T1-weighted image with fat saturation (d: arrowheads). Hyperselective catheterization of the anterior
trunk of the ascending pharyngeal artery (e: arrows) shows a tumor blush (e: arrowheads). Devascularization was achieved by inserting
controlled release microcoils (f: arrow) showing devascularization of the tumor process in a later view (f: arrowheads). After embolization,
biopsy showed a plasmacytoma allowing this to be managed speciﬁcally.
Figure 18. Embolization in Rendu-Osler disease. External carotid artery arteriography before embolization (a) showing distal hypervas-
cularization of the nasal fossa by branches of the sphenopalatine artery (a: black arrows) and by branches of the facial artery (a: white
arrows). A repeat view after embolization (b) carried out using 700 m microparticles shows satisfactory occlusion of the sphenopalatine
a
T
nd facial arteries. Note a symptomatic refeeding of the nasal fossa vasc
elangiectasiae are also present in the lingual artery (b: black arrow).ularization through the anterior ethmoidal artery (b: white arrow).
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Figure 19. Juvenile angioﬁbroma. T2-weighted axial (a), T1-weighted axial (b), T1-weighted after IV of gadolinium chelate and fat
saturation (c), ADC mapping (d), T2-weighted coronal (e) and T1-weighted 3D with gadolinium enhancement and fat saturation (f). A mass is
present in the right nasal fossa (a—d: arrows) exhibiting a few ‘‘ﬂow voids’’ on T2-weighted imaging (a: arrowheads) and vivid enhancement
after IV of gadolinium chelate (b, c), with no reduction in ADC values (1.4 × 10−3 mm2/sec, e: arrows) entering the sphenopalatine foramen
(e, f: arrows).
Figure 20. Juvenile angioﬁbroma. 3D dynamic gadolinium-chelate enhanced MR angiography every 4 seconds in a sagittal plane (a—f)
ptakeshowing the hypervascular nature of the lesion (a—f: arrowheads), uarteries (b: arrows).
 in which is almost synchronous with the basilar trunk and cerebral
770  A.  Reyre  et  al.
Figure 21. Preoperative embolization of a nasopharyngeal ﬁbroma. Nineteen-year-old male patient with a Radkowski classiﬁcation type
1B nasopharyngeal ﬁbroma. Diagnostic angiography of the external carotid artery (reﬂux into the internal, a) shows a tumor ‘‘blush’’ (a:
arrowheads) from the sphenopalatine artery (a: arrows). Devascularization was achieved by hyperselective catheterization and embolization
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pisodes of bradycardia. A repeat view shows complete devascular
onclusion
mbolization  now  currently  offers  huge  beneﬁt  in  the
anagement  of  epistaxis.  Its  results  are  improved  by  mul-
idisciplinary  collaboration  (surgeons  and  intensive  care
hysicians),  by  strictly  selecting  its  indications,  knowledge
f  the  vascular  anatomy  and  mastering  the  process  of  micro-
atheterization  and  the  embolization  agents.
Take-home  messages
• there  are  two  types  of  epistaxis:
◦ essential,
◦ symptomatic,  secondary  to  underlying  disease;
• arterial  embolization  is  a  treatment  of  choice  for
severe  refractory  and  symptomatic  epistaxis;
• full  knowledge  of  the  anatomy  of  the  branches  of  the
external  carotid  artery  is  an  essential  requirement
for  embolization.  Its  main  indications  are:
◦ essential  epistaxis  which  is  serious  from  the  outset
and  life  threatening  or  refractory  after  48  hours  of
correct  medical  treatment,
◦ severe  epistaxis  in  ORL  oncology  either  through
invasion  or  postoperatively,
◦ preoperative  devascularization  of  hypervascular
tumors  (paragangliomas  and  nasopharyngeal
ﬁbromas),
◦ frequent  episodes  of  epistaxis  in  Rendu-Osler
disease;
• the  treatment  of  benign  essential  epistaxis  is  initially
local  and  then  ‘‘crescendo’’  escalation;
• hemorrhages  from  the  anterior  ethmoidal  artery
require  surgical  treatment;
• the  occlusion  materials  vary  depending  on  the  type
of  epistaxis:
◦ microparticles  (from  500  to  700  microns)  for
essential  epistaxis  or  Rendu-Osler  disease,
◦ microcoils  or  glues,  particularly  in  secondaryepistaxis  or  with  hazardous  anastomoses,
◦ microcoils  are  not  recommended  in  Rendu-Osler
disease;
CEV3 Micro Therapeutics Inc., Irvine, CA) (b: arrowheads), with no
n of the mass (c: arrowheads).
• microparticles  can  only  be  used  when  no  hazardous
anastomoses  with  the  internal  carotid  artery  or
ophthalmic  artery  territory  are  present  and  require
free  ﬂow  injection  under  radioscopy  guidance;
• positioning  microcoils  may  be  a  good  alternative.
These  have  the  disadvantage  of  permanently
obstructing  the  artery  (re-embolization  is  impossible
in  the  event  of  recurrence);
• amongst  the  complications  of  arterial  embolization,
cerebrovascular  accident  and  central  retinal  artery
obstruction  are  the  most  severe;
• the  complication  rate  in  a  trained  operator’s  hands
is  no  greater  than  that  of  surgery.
linical case
 70-year-old  man  presents  with  recurrent  low  to  moderate
olume  epistaxis.  He  has  a  past  history  of  T2N0M0  conven-
ional  cell  renal  carcinoma,  and  a  coronary  stent  in  his  left
nterior  descending  artery.  Clinical  examination  reveals  a
ass  in  the  right  nasal  fossa.
An  MRI  is  performed  including:  T2-weighted  images  (A),
iffusion-weighted  MR  imaging  (B),  T1-weighted  images  (C),
ynamic  MR  angiography  (D),  a  time-intensity  (infusion)
urve  (E)  and  T1-weighted  gadolinium-chelate  enhanced
mage  (F)  (Fig.  22).
uestions
.  Describe  the  abnormalities  present  on  MR  images.
.  What  are  the  correct  answers?
.  The  epistaxis  is  secondary  to  a  right  nasal  fossa  tissue
lesion.
.  The  hypervascular  appearances  with  lavage  (E)  and
the  high  apparent  diffusion  coefﬁcient  of  the  lesion
−3 2(1.8  ×  10 mm /s;  B)  are  both  in  favor  of  a  hematoge-
nous  metastasis  from  a  renal  cancer.
.  The  patient’s  age  and  lack  of  invasion  of  the  pterygopala-
tine  groove  do  not  support  an  angioﬁbroma.
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Figure 22. Sinus MRI. a: T2-weighted axial MRI showing a well-delineated lesion in the right posterior nasal fossa with clear hyperintensity
on T2-weighted imaging; b: diffusion-weighted MRI (apparent diffusion coefﬁcient): the lesion has high ADC values; c: axial T1-weighted
imaging: right posterior nasal fossa lesion, isointense on T1-weighted imaging; d: dynamic MR angiography after IV administration of gadolin-
; e: 
adol
D
A
B
C
Dium chelate: early enhancement of the lesion in the arterial phase
of the lesion with a washout phase; f: T1-weighted MRI after IV of g
lesion.
.  A  biopsy  under  a  local  anesthetic  is  justiﬁed  before  exci-
sion  of  the  lesion.
E.  Receipt  of  anticoagulants  or  platelet  antiaggregants  is  a
contra-indication  to  possible  embolization.
3.  An  arteriography  is  performed  with  a  view  to  embolization
(Fig.  23).  What  are  the  correct  answers?.  Fig.  23a  is  a  selective  arteriography  view  of  the  exter-
nal  carotid  artery  showing  partial  opaciﬁcation  of  the
internal  carotid  artery  probably  due  to  reﬂux.
Figure 23. Arteriography. a: selective arteriography of the right exte
which has multiple arterial supplies including several branches of the int
artery and superior alveolar artery; b: hyperselective arteriography after 
is seen with the different arterial supplies; c: repeat hyperselective arter
Complete devascularization of the lesion. Note that the infra-orbital artT1-weighted DCE perfusion MRI showing the hypervascular nature
inium-chelate shows: extensive homogeneous enhancement of the
.  Fig.  23b  is  a hyperselective  arteriography  view  of  the
facial  artery  showing  a  tumor  blush  identical  in  size  to
series  (A).
.  Onyx® microcoils  and  calibrated  spherical  particles  ≥  700
m  are  both  embolization  agents  which  can  be  used.
.  Fig.  23c  is  a  hyperselective  arteriography  view  of  the
ending  of  the  internal  maxillary  artery  post-embolization
showing  complete  devascularization  of  the  blush  and
preservation  of  the  infra-orbital  and  descending  palatine
arteries.
rnal carotid artery showing a lesion blush within the la nasal fossa
ernal maxillary artery: sphenopalatine artery, descending palatine
microcatheterization of the internal maxillary artery: a lesion blush
iography after embolization with 700 m spherical microparticles.
ery is preserved.
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•72  
.  At  this  stage  in  the  procedure  (C),  the  lesion  may  carry
a  risk  of  revascularization  from  the  contralateral  or
intracranial  arterial  system.
Answers
1.  A:  MRI  T2-weighted  axial  section:  well-circumscribed
esion  in  the  right  posterior  fossa  with  hypersignal.
B:  MRI  diffusion-weighted  sequence  (apparent  diffusion
oefﬁcient):  this  lesion  shows  high  ADC  values.
C:  MRI  T1-weighted  axial  section:  isointense  lesion  of  the
ight  posterior  fossa.
D:  dynamic  MR  angiography  after  IV  of  gadolinium-
helate:  early  lesion  enhancement  in  the  arterial  phase.
E:  MRI  perfusion  sequence  T1  DCE:  hypervascular  nature
f  the  lesion  with  washing  stage.
F:  T1-weighted  MRI  after  IV  of  gadolinium-chelate:  large
nd  homogeneous  enhancement  of  the  lesion.
2.  Correct  answers:  A,  C.  Comments:
B:  the  high  ADC  suggests  a  benign  lesion.
D:  a  biopsy  is  contra-indicated  in  hypervascular  nasal
inus  lesions.
E:  embolization  is  particularly  justiﬁed  prior  to  surgical
xcision  if  the  patient  cannot  avoid  taking  an  anticoagulant
nd/or  platelet  antiaggregant  in  order  to  reduce  the  risks  of
leeding.
3.  Correct  answers:  A,  C,  D,  E.  Comments:
B:  internal  maxillary  artery  (ending).  This  patient
nderwent  distal  embolization  with  calibrated  spherical
icroparticles  ≥  700  m  in  size  (Embozen® Mircrosphere
00  m  CeloNova©,  C)  followed  by  occlusion  of  the  trunk  of
he  internal  maxillary  artery  with  microcoils.  No  signiﬁcant
leeding  occurred  on  endonasal  excision.  The  ﬁnal  diagnosis
as  a  benign  angiomatous  nasal  fossa  polyp.
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ppendix A. Appendix Practical guide to
he  endovascular treatment of epistaxis
nvironment
ultidisciplinary  group  in  a  radiology  suite:  ENT
urgeon—Anesthetist—Interventional  Radiologist.
‘
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ndication
Posterior  epistaxis,  refractory  after  48  hours  of  correct
medical  treatment
Serious  epistaxis,  life  threatening  from  the  outset.
ssessment of patient status
n all cases
aboratory  assessment:  PR  APTT  INR,  CBC,  platelets  and
lood  group.
ontrolled hemorrhage
ssessment  of  cause  and  feasibility  assessment:  Supra-aortic
essel  CT  angiography  from  the  aortic  arch  to  the  circle  of
illis  and  facial  bone  CT.
emodynamic stability not controlled by
ntensive care
ither  endovascular  treatment  with  embolization  or  surgery
hould  be  discussed  with  the  ENT  surgeons  and  intensive  care
hysicians.
n the operating suite
atient  placed  lying  down  with  a  head  rest,  sedated,
adioscopy  in  position,  infusion,  informed  and  ‘‘reassured’’.
One  operator,  one  operator’s  assistant  and  an  operating
uite  technician.
Anesthetist/Intensive  care  physician  for  station  and  gen-
ral  anesthesia  if  required,  monitoring  and  correcting
emodynamic  indices.
n the angiography table
F  valve  introducer.  Consider  35  cm  long  introducer  depend-
ng  on  morphology  of  the  iliofemoral  arterial  system.  6F
uide  catheter  (Envoy®,  100  cm)  on  0.035′’  hydrophilic  guide
Terumo®) and  antireﬂux  valve.
Microcatheter  (at  least  135  cm  long)  suitable  for  the
mbolization  agents  (compatible  with  Onyx® if  necessary)
ith  a  straight  or  preshaped  (45◦ or  90◦)  tip  and  two  radio-
paque  markers  if  controlled  release  coils  are  used.  45◦
nd  90◦ curved  hydrophilic  microguides.  The  introducers,
atheters  and  microcatheters  should  be  rinsed  and  infused
y  bags  and  blood  pressure.
n the angiography suite trolley
Microcoils  suitable  for  the  microcatheter.
Calibrated  microparticles  (Luer-lock  syringe  preﬁlled  to
500—700  m).
Cyanoacrylates,  (Histoacryle® or  Glubran2®).
Ethylene  vinyl  alcohol  copolymer  (Onyx®), rarely  used  in
emergencies.‘Conventional’’ procedure
emoral  artery  approach,  valve  introducer  rinsed  and  per-
used,  guide  catheter  rinsed  and  perfused.
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[Epistaxis:  The  role  of  arterial  embolization  
• Injection  into  the  common  carotid  artery  after  selective
catheterization  of  the  bleeding  side  with  long  series  to
study  jugular  venous  return.
• Selective  injection  of  the  internal  carotid  artery  with
anteroposterior  and  lateral  views  (to  study  the  ophthalmic
artery  and  anterior  ethmoidal  artery).
• Selective  injection  of  the  external  carotid  artery,  postero-
anterior  and  lateral  views  including  the  nasal  fossae  in  the
ﬁeld.
• Investigation  for  the  target  and  identifying  hazardous
anastomoses:  foramen  lacerum  artery,  clival  branches,
pterygoid  artery,  foramen  ovalis  artery,  foramen  rotun-
dum  artery  and  in  the  ophthalmic  artery.
• Use  of  a  microguide  and  microcatheter  couple  from  the
start  leaving  a  guide  catheter  at  the  origin  of  the  external
carotid  artery.  Hyperselective  microcatheterization  of  the
target  (failing  this  the  sphenopalatine  artery).
• Use  of  arterial  tracing.  Do  not  catheterize  the  branches  of
the  external  carotid  artery  with  the  0.035  guide  to  avoid
spasm.
If  hazardous  anastomoses  are  present,  place  the  micro-
catheter  beyond  the  anastomosis  but  always  consider  the
risk  of  reﬂux  during  embolization.  If  necessary,  carry  out
proximal  embolization  (of  the  trunk)  of  the  hazardous  anas-
tomosis  using  microcoils  before  the  microparticles.
In  the  event  of  arterial  spasm,  to  enable  free  ﬂow
embolization,  use  an  in  situ  intra-arterial  perfusion  of
nitrates  (1  mg  of  Risordan®)  with  the  agreement  of  the
anesthetist-intensive  care  physician.
Embolization  always  free  ﬂow  as  close  as  possible  to  the
target  and  a  radioscopy  control.
Angiography  images  are  taken  routinely  at  the  end  of
the  procedure  to  investigate  for  collateral  circulation  and
revascularization  of  the  target.  If  the  sphenopalatine  artery
is  revascularized  from  the  facial  artery,  the  facial  artery
should  be  embolized  with  very  distal  microspheres  or  micro-
coils.
The  ﬁnal  check  investigates  for  revascularization  of  the
nasal  fossa  particularly  by  the  ethmoidal  arteries.
Leave  the  femoral  introducer  in  situ  until  hemodynamic
and  neurological  control  has  been  conﬁrmed  clinically  by  the
ORL  team  in  the  angiography  suite.
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